The U.S. is experiencing a shift in the regulatory environment for animal testing, driven by the evolving use of AI. This impacts the formulation development approach for new drugs in the non-clinical phase.
- From Matrix To Medicine: New Frontiers In Treating Pulmonary Fibrosis And PH
- Formulation Development Of A JAK1 Inhibitor Extended-Release Tablet
- Advanced Process Risk Assessment And Control Strategy Development In Solid Oral Dosage Forms
- 3 Lesser Known Keys To Effective Biopharma Supplier Engagement
- Connected Drug Delivery Devices: Emerging Market Trends
- Tips From A Biomedical Engineer For Medical Device Innovation And Compliance
- Formulation Is Key For Y-mAbs' Self-Assembling Antibody
- The Future Of Biologics Delivery: High-Concentration Subcutaneous Injectables
ON-DEMAND WEBINARS
High concentration formulations often present challenges with regard to viscosity as well as potential changes in the behavior upon stability. Discover solutions to mitigate high viscosity.
Launching a large molecule in one format and then switching the delivery format often transpires as a lifecycle management strategy for cost efficiency, supply chain continuity, and patient benefit.
Gain valuable insights into the jet milling process and Quality by Design approach for inhalation drug delivery and their potential applications in drug development.
Discover how PBPK models combined with in vitro tools and solubility enhancement expertise can be used to identify and mitigate absorption risks in early drug development.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Prefilled Syringe GettyImages-1284529278]( "Prioritize Your Finished Goods Experience To Safely Deliver Medicine")
Prioritize Your Finished Goods Experience To Safely Deliver MedicineAs demand forecasts evolve, opt to work with a CDMO that can pivot manufacturing strategies seamlessly while accommodating your end-to-end needs, from drug substance to finished goods.
-
![Modern-Medical-Research-Lab-GettyImages-1293773029]( "The Formulation Development Journey")
The Formulation Development JourneySuccessful formulation journeys start with a roadmap where scientific studies and decision points create a route for understanding a molecule’s personality and its viability to help it along the way to the patients.
-
![GettyImages-946264472-test-tube-lab]( "Selecting Container Closure Components: A Data-Driven Approach To CCI")
Selecting Container Closure Components: A Data-Driven Approach To CCIDiscover an efficient, data-driven process that employs innovative methods to accelerate the selection of a closure containment system that meets the requirements of the modern regulatory landscape.
-
![GettyImages-1310024666-genetic-digital-dna]( "How Nanoparticle Platforms Are Unlocking Genetic Medicine's Potential")
How Nanoparticle Platforms Are Unlocking Genetic Medicine's PotentialExplore how the HIT SCAN platform accelerates gene therapy delivery by screening polymeric nanoparticles, enhancing precision and regulatory pathways for next-generation genetic medicines.
-
![Signing contract-GettyImages-1405364155]( "Contract Design And Development Vs. In-House: How To Find The Best Fit")
Contract Design And Development Vs. In-House: How To Find The Best FitExplore the rationale behind opting for a contract development organization (CDO) to fulfill organizational requirements and underscore vital considerations for evaluating CDOs to ensure alignment with your project objectives.
-
![Nanoform]( "Small Is Powerful And Sustained")
Small Is Powerful And SustainedAdvances in sustained-release drug delivery could improve efficiency and consistency in drug release, manifesting real-life advantages for patients in the form of enhanced accessibility and compliance.
-
![GettyImages-1428557022-Liposome]( "Liposomes – Challenges And Opportunities")
Liposomes – Challenges And OpportunitiesLiposome technology is an effective drug delivery tool but still presents difficulties. Learn how developers are meeting these challenges and the opportunities for advancement to maximize liposome usefulness.
-
![GettyImages-1354172420-lab-development]( "Integrating Early-Phase Clinical Supply Manufacturing & Distribution")
Integrating Early-Phase Clinical Supply Manufacturing & DistributionA tablet formulation was a solution when developing a new class of anti-infective medicine, allowing the integration of formulation development, clinical trial material (CTM) manufacturing, and supply and distribution to patients.
-
![Stevanato]( "Overcoming A Failed Design Verification Test For Your Delivery Device")
Overcoming A Failed Design Verification Test For Your Delivery DeviceIf a drug delivery device fails a design verification test, the consequences can be lost revenue for the pharma company and delays for patients. Explore how to eliminate design verification failure.
-
![GettyImages-1353123922-doctor-patient]( "Why 'Off-The-Shelf' Devices Do Not Circumvent Design Controls")
Why 'Off-The-Shelf' Devices Do Not Circumvent Design ControlsUtilizing off-the-shelf (OTS) devices for drug delivery can offer significant advantages to development programs in timeline and risk mitigation. Understand the design control responsibilities of a sponsor when using OTS devices.
Tom hosts multiple videocast series providing expert takes and insider perspectives on drug delivery:
In her monthly column, Fran offers keen industry insights exclusively on Drug Delivery Leader.
FRANKLY FRAN
-
![frankly-fran-better]( "Drug Delivery Innovation: If You Build It, Will Anyone Care?")
In this article, Fran DeGrazio explains why innovation in drug delivery technologies may not need to be revolutionary, but will no doubt need patient adoption, payor support, and regulatory follow-on to become sticky in the marketplace.
FREE EBOOK: COMBINATION PRODUCTS
Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.
